CHENNAI: With artificial intelligence taking over Industrial 4.0, a Bengaluru-based startup, RxPrism, has set out to revolutionise the traditional clinic/ hospital space. Founded by a doctor-engineer, it provides AI-enabled technology to pharma companies and hospitals to enhance pharma-doctor and doctor-patient relationship.
The company provides pharma companies with tech support to operate Rep Bots, where these bots can explain to a doctor how a particular drug works. This eliminates the hassle for doctors to make time for medical reps, and the bots can explain the drug in a more scientific manner than a medical rep could.
Additionally, RxPrism helps pharma companies provide an app, which the doctor can share with the patient after the prescription.
The physician can interact with the patient over the app to monitor progress or address any clarifications. This service is of particular use for chronic long term ailments, according to Dr Maruthi Viswanathan, founder-CEO, RxPrism Health Systems.
They work with most of the top 20 pharma and medical device companies in the world as clients including J&J, Pfizer, Sanofi, Abbott, Merck, Takeda, Novartis, Eli Lilly, Novo Nordisk, Dr Reddy’s, Mylan, Biocon, Sun, Allergan and Carl Zeiss.
Viswanathan is both a trained doctor and an engineer. “I took this up out of passion. When I was in medical college, I used to help professors visualise their presentations with simulations. This had become a business for me. Later, everyone advised me to continue the same in a bigger scale. I went to the US and trained in technology before launching this startup,” he said.
By August 2017, RxPrism will launch a new doctor technology interface to help patients get in touch with doctors online . This would help people from different countries connect with doctors globally, without any geographical barriers or agents to facilitate medical tourism. “Locally, you can connect with your doctor without worrying about visiting the clinic for things that could be solved virtually,”
he explained.
The company has also filed a patent for RxKiosk, wherein a hospital visitor can connect to Wi-Fi and complete registration formalities online. “Once a person logs in, the kiosk remembers and identifies the individual during their next visit. This requires a smartphone and WiFi,” added Viswanathan.
Another innovation in the pipeline is RsExTV, a TV extender adapter device that allows users to extend a TV screen or channel to their mobile phones, laptops, or other portable devices with a multichannel viewing option. These features are likely to be in the market later this year.
Founded in 2013, the company is all set to make its mark in the UK by opening a Regional Innovation Hub. The company, which has been invited by Mayor of London’s inward investment company, London & Partners is planning to widen its horizon in the UK and EU.
RxPrism is now raising ‘Series A’ funding which is close to $5 million. Right now, the company employs around 100 people, nearly half of whom are engaged in the R&D space. In two years, they aim to grow to a team of 250 and more.